# US 2018/0320217 A1 · Methods for sampling and measuring oral lavage proteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0320217 A1
- Document ID: US20180320217A1
- Status: Published application
- Kind: A1
- Application number: 15/971,719
- Filed: 2018-05-04
- Published: 2018-11-08
- Earliest claimed: 2017-05-04
- Assignees: The Procter & Gamble Company
- Applicants: The Procter & Gamble Company
- Inventors: John Christian HAUGHT; Sancai XIE; Cheryl Sue TANSKY
- Web page: https://patentgrep.com/patent/US20180320217A1

## CPC

- C12Q 1/32: involving dehydrogenase
- C12Q 1/008: {for determining co-enzymes or co-factors, e.g. NAD, ATP}
- C12Q 2326/90: Developer
- G01N 2800/18: Dental and oral disorders
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method for reducing a tetrazolium salt.

## Claims

### Claim 1

A method for reducing a tetrazolium salt comprising:
providing an oral cavity sample;
combining the oral cavity sample with a tetrazolium salt;
wherein the oral cavity sample comprises an enzyme and at least one of a dehydrogenase, reductase or reducing reagent; and
wherein the tetrazolium salt is reduced to produce a formazan dye.

### Claim 2 (depends on 1)

The method of claim 1, wherein a biomarker is extracted from oral lavage, gingival brush samples and supragingival and subgingival plaques.

### Claim 3 (depends on 2)

The method of claim 2, wherein the biomarker is extracted using, sonication, vortex and centrifugation.

### Claim 4 (depends on 2)

The method of claim 2, wherein the extracted biomarker is analyzed with at least one of immunoassay, gradient hydrophilic interaction liquid chromatography with tandem mass spectrometry (HILIC/MS/MS), enzymatic assay, or colorimetric assay to quantify the levels of at least one of protein or enzyme.

### Claim 5 (depends on 2)

The method of claim 2, wherein the biomarker is a protein.

### Claim 6 (depends on 5)

The method of claim 5, wherein the protein is involved in glycolysis or cellular respiration pathway.

### Claim 7 (depends on 5)

The method of claim 5, wherein the protein is at least one of: aldolase, triosephosphate isomerase, glyceraldehyde phosphate dehydrogenase, phosphoglycerate kinase, phosphoglycerate mutase, enolase, pyruvate dehydrogenase, lactate dehydrogenase, alcohol dehydrogenase, aconitase, isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, succinyl coenzyme A synthetase, succinate dehydrogenase, fumarase, or malate dehydrogenase.

### Claim 8 (depends on 2)

The method of claim 2, wherein the biomarker is a metabolite.

### Claim 9 (depends on 1)

The method of claim 1, wherein the oral cavity sample comprises at least one of oral lavage sample, gingival brush sample, or gingival plaque sample.

### Claim 10 (depends on 1)

The method of claim 1 wherein the oral cavity sample comprises a substrate.

### Claim 11 (depends on 1)

The method of claim 1, wherein the oral cavity sample comprises an electron coupling reagent.

### Claim 12 (depends on 11)

The method of claim 11 wherein the electron coupling reagent is at least one of diaphorase, 1-Methoxy-5-methylphenazinium methyl sulfate, 5-Methylphenazinium methyl sulfate, or Phenazine ethosulfate.

### Claim 13 (depends on 1)

The method of claim 1, wherein the tetrazolium salt is at least one of MTT, EZMTT, MTS, XTT, INT, Nitro-TB, WST-1, WST-4, WST-5, WST-8, or WST-9.

### Claim 14 (depends on 1)

The method of claim 1, wherein the oral cavity sample comprises a cofactor.

### Claim 15 (depends on 14)

The method of claim 14, wherein cofactor is at least one of NAD+, NADP+, NADH, or NADPH.

### Claim 16

A method for reducing resazurin comprising:
providing an oral cavity sample;
combining the oral cavity sample with resazurin;
wherein the oral cavity sample comprises an enzyme and at least one of a dehydrogenase, reductase or reducing reagent; and
wherein the resazurin is reduced to produce resorufin.
